It is still too early to draw definitive conclusions, but the numerous ongoing clinical trials, including the cardiovascular safety trial versus an active comparator (dulaglutide), the first of its kind, will provide us shortly with important confirmations
This guide explains how to access GLP-1 medications cost-effectively, eligibility criteria for NHS prescriptions, and factors affecting overall treatment expenses, helping you make informed decisions about affordable diabetes and weight management care
doi:10.1370/afm.1517
Treatment with exenatide has been shown to decrease food intake and attenuate food-related neural responses in key regions such as the insula, amygdala, putamen, and orbitofrontal cortex (van Bloemendaal et al., 2014)
Psoriasis and the risk of diabetes: A prospective population-based cohort study